7 stats on OTC drugs in America
Published Updated
1 Min Read
For reprint and licensing requests for this article, click here.
More From Employee Benefit News
Benefits Think The most practical healthcare innovation in America isn’t coming from Silicon Valley
Public sectors are approaching chronic disease support out of necessity, leading to benefits that build a stronger workforce.
Ellen Rudolph
WellTheory
How Bank of America helps employees handle life’s biggest events
The company's Life Event Services team guides colleagues through resources and benefits that make major milestones easier to manage, and has worked on more than 700,000 cases over 12 years.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
GLP-1 drug use surges, along with coverage costs for employers
As more Americans turn to GLP-1 medications for weight loss, employers are weighing the benefits of coverage against rising healthcare expenses and long-term costs.
